Granules India Gains 5% on US FDA Approval for ADHD Drug
On Friday, Granules India’s shares jumped as much as 5 per cent after it received USFDA approval complex Attention Deficit Hyperactivity Disorder (ADHD) Drug. The Indian pharmaceutical...
Download Unicorn Signals App
Powered By EquityPandit
